Emanuela Onesti

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Glutamate-Mediated Blood-Brain Barrier Opening: Implications for Neuroprotection and Drug Delivery

Udi Vazana, Ronel Veksler, Gaby S. Pell et al. · Journal of Neuroscience · 2016 · 204 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Comparison of the effects of acetyl l-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial

Valentina Tomassini, Carlo Pozzilli, Emanuela Onesti et al. · Journal of the Neurological Sciences · 2003 · 165 citations

Medicine, Neurology, Pharmacology +8

Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis

Francesco Patti, Carlo Pozzilli, E. Montanari et al. · Multiple Sclerosis Journal · 2007 · 136 citations

Medicine, Neurology, Disability Management +12

Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis

K. Hewett, Donald B. Sanders, Richard Grove et al. · Neurology · 2018 · 128 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14